FormWeb • Hazardous Drugs

Henry Ford Health

Approved Hospital Formulary

FormWeb QuickStart Questions or Suggestions? Pharmacy Intranet

Add Formweb to your mobile device

Brand name products with an equivalent generic may not be available to order at Henry Ford Health. For questions, contact inpatient pharmacy.

Henry Ford Health

Approved Hospital Formulary

FormWeb QuickStart Questions or Suggestions? Pharmacy Intranet

Hazardous Drugs

Please review each of these drugs carefully.

abacavir	Table 2 - Specific Handling Instructions
abacavir-lamivudine	Table 2 - Specific Handling Instructions
abacavir/dolutegravir/lamivudine	Table 2 - Specific Handling Instructions
acitretin	Table 2 - Specific Handling Instructions
ado-trastuzumab emtansine	Table 1 - Specific Handling Instructions
aflibercept ophthalmic	Table 2 - Specific Handling Instructions
ambrisentan	Table 2 - Specific Handling Instructions
amivantamab	Table 2 - Specific Handling Instructions
anastrozole	Table 2 - Specific Handling Instructions
arsenic trioxide	Table 1 - Specific Handling Instructions
azaCITIDine	Table 1 - Specific Handling Instructions
azaTHIOprine	Table 2 - Specific Handling Instructions
BCG	Table 1 - Specific Handling Instructions
belantamab mafodotin	Table 1 - Specific Handling Instructions
bendamustine	Table 1 - Specific Handling Instructions
bicalutamide	Table 2 - Specific Handling Instructions
bleomycin	Table 1 - Specific Handling Instructions
blinatumomab	Table 2 - Specific Handling Instructions
bortezomib	Table 1 - Specific Handling Instructions
bosentan	Table 2 - Specific Handling Instructions
brentuximab vedotin	Table 1 - Specific Handling Instructions
busulfan	able 1 - Specific Handling Instructions
cabazitaxel	Table 1 - Specific Handling Instructions
capecitabine	Table 1 - Specific Handling Instructions
carBAMazepine	Table 2 - Specific Handling Instructions
CARBOplatin	Table 1 - Specific Handling Instructions
carfilzomib	Table 1 - Specific Handling Instructions
carmustine	Table 1 - Specific Handling Instructions
cenobamate	Table 2 - Specific Handling Instructions
chorionic gonadotropin (HCG)	Table 2 - Specific Handling Instructions
cidofovir	Table 1 - Specific Handling Instructions
CISplatin	Table 1 - Specific Handling Instructions
cladribine	Table 1 - Specific Handling Instructions
cloBAZam	Table 2 - Specific Handling Instructions
clonazePAM	Table 2 - Specific Handling Instructions
colchicine	Table 2 - Specific Handling Instructions
conjugated estrogens	Table 1 - Specific Handling Instructions
conjugated estrogens topical	Table 1 - Specific Handling Instructions
cyclophosphamide	Table 1 - Specific Handling Instructions
cycloSPORINE	Table 1 - Specific Handling Instructions
cytarabine	Table 1 - Specific Handling Instructions
cytarabine liposomal-daunorubicin liposomal	Table 1 - Specific Handling Instructions
dacarbazine	Table 1 - Specific Handling Instructions
DACTINomycin	Table 1 - Specific Handling Instructions
DAUNOrubicin	Table 1 - Specific Handling Instructions
decitabine	Table 1 - Specific Handling Instructions
degarelix	Table 2 - Specific Handling Instructions
dexrazoxane	Table 1 - Specific Handling Instructions
dihydroergotamine	Table 2 - Specific Handling Instructions
divalproex sodium	Table 2 - Specific Handling Instructions
DOCEtaxel	Table 1 - Specific Handling Instructions
DOXOrubicin	Table 1 - Specific Handling Instructions
DOXOrubicin liposomal	Table 1 - Specific Handling Instructions
dronedarone	Table 2 - Specific Handling Instructions
enfortumab vedotin-ejfv	Table 1 - Specific Handling Instructions
entecavir	Table 2 - Specific Handling Instructions
epiRUBicin	Table 1 - Specific Handling Instructions
eriBULin	Table 2 - Specific Handling Instructions
erlotinib	Table 2 - Specific Handling Instructions
esterified estrogens-methyltestosterone	Table 1 - Specific Handling Instructions
estradiol	Table 2 - Specific Handling Instructions
estradiol topical	Table 2 - Specific Handling Instructions
etonogestrel	Table 2 - Specific Handling Instructions
etoposide	Table 1 - Specific Handling Instructions
etoposide phosphate	Table 1 - Specific Handling Instructions
everolimus	Table 1 - Specific Handling Instructions
fam-trastuzumab deruxtecan-nxki	Table 1 - Specific Handling Instructions
finasteride	Table 2 - Specific Handling Instructions
floxuridine	Table 1 - Specific Handling Instructions
fluconazole	Table 2 - Specific Handling Instructions
fludarabine	Table 1 - Specific Handling Instructions
fluorouracil	Table 1 - Specific Handling Instructions
fluorouracil topical	Table 1 - Specific Handling Instructions
flutamide	Table 2 - Specific Handling Instructions
fulvestrant	Table 2 - Specific Handling Instructions
ganciclovir	Table 1 - Specific Handling Instructions
gemcitabine	Table 1 - Specific Handling Instructions
gemtuzumab ozogamicin	Table 1 - Specific Handling Instructions
goserelin	Table 2 - Specific Handling Instructions
histrelin	Table 2 - Specific Handling Instructions
hydrochlorothiazide-spironolactone	Table 2 - Specific Handling Instructions
HYDROXYprogesterone	Table 2 - Specific Handling Instructions
hydroxyurea	Table 1 - Specific Handling Instructions
IDArubicin	Table 1 - Specific Handling Instructions
idecabtagene vicleucel	Table 1 - Specific Handling Instructions
ifosfamide	Table 1 - Specific Handling Instructions
imatinib	Table 1 - Specific Handling Instructions
irinotecan	Table 1 - Specific Handling Instructions
irinotecan liposomal	Table 1 - Specific Handling Instructions
ivabradine	Table 2 - Specific Handling Instructions
ixabepilone	Table 1 - Specific Handling Instructions
lamivudine-zidovudine	Table 2 - Specific Handling Instructions
letrozole	Table 2 - Specific Handling Instructions
leuprolide	Table 2 - Specific Handling Instructions
levonorgestrel-releasing intrauterine system	Table 2 - Specific Handling Instructions
lisocabtagene maraleucel	Table 1 - Specific Handling Instructions
lomustine	Table 1 - Specific Handling Instructions
lurbinectedin	Table 1 - Specific Handling Instructions
macitentan	Table 2 - Specific Handling Instructions
maribavir	Table 2 - Specific Handling Instructions
medroxyPROGESTERone	Table 2 - Specific Handling Instructions
megestrol	Table 2 - Specific Handling Instructions
melphalan	Table 1 - Specific Handling Instructions
mercaptopurine	Table 1 - Specific Handling Instructions
methIMAzole	Table 2 - Specific Handling Instructions
methotrexate	Table 1 - Specific Handling Instructions
methylergonovine	Table 2 - Specific Handling Instructions
midostaurin	Table 2 - Specific Handling Instructions
miFEPRIStone	Table 2 - Specific Handling Instructions
mirvetuximab soravtansine	Table 1 - Specific Handling Instructions
miSOPROStol	Table 2 - Specific Handling Instructions
mitoMYcin	Table 1 - Specific Handling Instructions
mitoMYcin ophthalmic	Table 1 - Specific Handling Instructions
mitotane	Table 1 - Specific Handling Instructions
mitoXANTRONE	Table 1 - Specific Handling Instructions
mycophenolate mofetil	Table 2 - Specific Handling Instructions
mycophenolic acid	Table 2 - Specific Handling Instructions
nevirapine	Table 2 - Specific Handling Instructions
oxaliplatin	Table 1 - Specific Handling Instructions
OXcarbazepine	Table 2 - Specific Handling Instructions
oxytocin	Table 2 - Specific Handling Instructions
PACLitaxel	Table 1 - Specific Handling Instructions
PACLitaxel protein-bound	Table 1 - Specific Handling Instructions
paliperidone	January 10th, 2019 NIOSH has determined it is unlikely that paliperidone (Invega®) poses a carcinogenic, reproductive or developmental hazard to workers in a healthcare setting and is no longer considered a hazardous drug by NIOSH.
pamidronate	Table 2 - Specific Handling Instructions
PARoxetine	Table 2 - Specific Handling Instructions
PEMEtrexed	Table 1 - Specific Handling Instructions
pentostatin	Table 1 - Specific Handling Instructions
phenytoin	Table 2 - Specific Handling Instructions
plerixafor	Table 2 - Specific Handling Instructions
progesterone	Table 2 - Specific Handling Instructions
propylthiouracil	Table 2 - Specific Handling Instructions
rasagiline	Table 2 - Specific Handling Instructions
ravulizumab	Table 2 - Specific Handling Instructions
ribavirin	Table 2 - Specific Handling Instructions
riociguat	Table 2 - Specific Handling Instructions
risperiDONE	January 10th, 2019 NIOSH has determined it is unlikely that risperidone (Risperidal®) poses a carcinogenic, reproductive, or developmental hazard to workers in a healthcare setting and is no longer considered a hazardous drug by NIOSH.
romiDEPsin	Table 1 - Specific Handling Instructions
sacituzumab govitecan	Table 1 - Specific Handling Instructions
sipuleucel-T	Table 1 - Specific Handling Instructions
sirolimus	Table 2 - Specific Handling Instructions
spironolactone	Table 2 - Specific Handling Instructions
streptozocin	Table 1 - Specific Handling Instructions
tacrolimus	Table 2 - Specific Handling Instructions
talquetamab	Table 2 -Specific Handling Instructions
tamoxifen	Table 1 - Specific Handling Instructions
teclistamab	Table 2 - Specific Handling Instructions
temazepam	Table 2 - Specific Handling Instructions
temsirolimus	Table 1 - Specific Handling Instructions
teprotumumab-trbw	Table 2 - Specific Handling Instructions
testosterone	Table 2 - Specific Handling Instructions
thiotepa	Table 1 - Specific Handling Instructions
topiramate	Table 2 - Specific Handling Instructions
topotecan	Table 1 - Specific Handling Instructions
tremelimumab	Table 1 - Specific Handling Instructions
tretinoin	Table 2 - Specific Handling Instructions
tretinoin topical	Table 2 - Specific Handling Instructions
trifluridine ophthalmic	Table 1 - Specific Handling Instructions
valGANciclovir	Table 1 - Specific Handling Instructions
valproic acid	Table 2 - Specific Handling Instructions
venetoclax	Table 1 - Specific Handling Instructions
vinBLAStine	Table 1 - Specific Handling Instructions
vinCRIStine	Table 1 - Specific Handling Instructions
vinCRIStine liposome	Table 1 - Specific Handling Instructions
vinorelbine	Table 1 - Specific Handling Instructions
voriconazole	Table 2 - Specific Handling Instructions
warfarin	Table 2 - Specific Handling Instructions
zidovudine	Table 2 - Specific Handling Instructions
ziprasidone	Table 2 - Specific Handling Instructions
zoledronic acid	Table 2 - Specific Handling Instructions
zonisamide	Table 2 - Specific Handling Instructions

This site is intended for the staff of Henry Ford Health.
While others may view accessible pages, Henry Ford Health makes no warranty, express or implied,
as to the use of this information outside of Henry Ford Health.